<DOC>
	<DOCNO>NCT01930994</DOCNO>
	<brief_summary>A cross-sectional study compare pharmacokinetics Sino-implant ( II ) four year use Jadelle five year use Kenyan woman .</brief_summary>
	<brief_title>Kenya Sino-implant ( II ) PK Study</brief_title>
	<detailed_description>A cross-sectional study compare pharmacokinetics Sino-implant ( II ) four year use Jadelle five year use Kenyan woman . The active ingredient implant levonorgestrel ( LNG ) synthetic progestin use combined oral contraceptive progestin-only pill 30 year . Population : A total 280 woman age 18 44 year currently use Sino-implant ( II ) Jadelle contraceptive implant enrol one six cohort woman : Cohort 1 : ( n=20 Sino-implant ( II ) , n=20 Jadelle ) woman enrol 1-3 month 6-month insertion anniversary . Cohort 2 : ( n=20 Sino-implant ( II ) , n=20 Jadelle ) woman enrol 1-3 month 12-month insertion anniversary . Cohort 3 : ( n=20 Sino-implant ( II ) , n=20 Jadelle ) woman enrol 1-3 month 24-month insertion anniversary . Cohort 4 : ( n=20 Sino-implant ( II ) , n=20 Jadelle ) woman enrol 1-3 month 36-month insertion anniversary . Cohort 5 : ( n=40 Sino-implant ( II ) , n=40 Jadelle ) woman enrol 1-3 month 48-month insertion anniversary . Cohort 6 : ( n=40 Jadelle ) woman enrol 2-6 month 60-month insertion anniversary . Women cohorts follow 6 month . Study Duration : Up 6 month participant recruitment 6 month elapse baseline visit second study visit . 15 month total field include training , study initiation , recruitment , follow-up , close-out . Two blood sample space 2 6 month apart draw woman hormone measurement . Primary Objective : To compare total free levonorgestrel ( LNG ) plasma concentration four year Sino-implant ( II ) use total free LNG plasma concentration five year Jadelle use Kenyan woman Secondary Objectives : 1 . To compare total free LNG plasma concentration four year Sino-implant ( II ) use total free LNG plasma concentration four year Jadelle use 2 . To characterize total free LNG plasma concentration-time profile four year follow Sino-implant ( II ) five year follow Jadelle insertion 3 . To characterize sex hormone bind globulin ( SHBG ) serum concentration-time profile four year follow Sino-implant ( II ) five year follow Jadelle insertion</detailed_description>
	<criteria>Have Sinoimplant ( II ) Jadelle implant set place , confirm physical exam ; Have confirm contraceptive implant insertion date consistent criterion cohort enrol ; Be age 18 44 year , inclusive ; Not wish become pregnant next six month ; Not desire implant removal within next six month . Be able understand information give make personal decision whether participate study ; Consent participation , sign inform consent form ; Agree able return clinic second study visit . The following criterion exclude participation study : Use rifampicin , and/or anticonvulsant ( barbiturate , phenytoin , phenobarbital , carbamazepine , oxcarbazepine , primidone , topiramate ) , and/or herbal product contain St. John 's wort ( Hypericum perforatum ) , selfreport ; 7 Use medication contain LNG hormone impact LNG SHBG disposition , e.g . treatment LNG oral contraceptive bleed disturbance , selfreport ; Use antiretroviral drug , selfreport ; Any condition ( social medical ) opinion Investigator would make study participation unsafe , would interfere adherence study requirement complicate data interpretation .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>LNG : Levonorgestrel</keyword>
	<keyword>MSI : Marie Stopes International</keyword>
	<keyword>MSK : Marie Stopes Kenya</keyword>
	<keyword>PK : Pharmacokinetic</keyword>
</DOC>